glp 1 drugs for rheumatoid arthritis GLP-1s Arthritis: Can These Weight Loss Help With RA? GLP-1 Receptor Agonists May Improve
Description
As a neurologist and long-time specialist in ME/CFS/FM, EDS, and now long COVID, Dr
Rosenstock J, Wysham C, Fras JP et al (2021) Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, et al
Pharmaceutical companies are actively investing in research and development to expand their portfolios, introducing novel formulations and delivery methods
Three triple agonists are currently in clinical trials: retatrutide (Eli Lilly), HM15211 (Hanmi Pharmaceutical), and SAR441255 (Sanofi)
However, from a practical standpoint, the immediate reduction of appetite is not a universal experience
